A comparison of the effects of inhaled furosemide and ethacrynic acid on sodium-metabisulfite-induced bronchoconstriction in subjects with asthma.

Inhaled furosemide prevents bronchoconstriction induced by a number of challenges in asthma. One approach to determine the mechanism underlying this protection has been to examine the effects of diuretics with different or overlapping pharmacologic effects. We have compared the effects of furosemide on sodium metabisulfite-induced bronchoconstriction with those of equivalent diuretic doses of ethacrynic acid, a loop diuretic that, unlike furosemide, does not interact directly with the membrane Na/K/Cl cotransporter protein or inhibit carbonic anhydrase. Eight subjects with mild asthma were studied on five occasions, receiving nebulized furosemide (20 and 40 mg), ethacrynic acid (25 and 50 mg), or placebo (normal saline) in random order and double-blind 10 min before a cumulative dose challenge with inhaled sodium metabisulfite. After placebo the geometric mean sodium metabisulfite PD20 was 7.9 mumol. Furosemide 20 mg and 40 mg increased the PD20 by a mean 1.1 (95% confidence interval, -0.2-2.4; p > 0.05) and 1.6 (0.4-2.9; p < 0.02) doubling doses to 17.1 and 24.7 mumol, respectively. After inhaled ethacrynic acid 25 mg and 50 mg, the geometric mean PD20 was increased by 0.9 (-0.4-2.2; p > 0.05) and 1.5 (0.2-2.8; p < 0.05) doubling doses to 14.5 and 22.4 mumol, respectively. Thus, equivalent diuretic doses of furosemide and ethacrynic acid have a similar inhibitory effect on sodium metabisulfite-induced bronchoconstriction in asthma. This suggests that interaction with the Na/K/Cl cotransporter protein, or carbonic anhydrase inhibition, is not relevant to the effects of furosemide in asthma.

[1]  K. Chung,et al.  Inhibition of sodium metabisulphite induced bronchoconstriction by frusemide in asthma: role of cyclooxygenase products. , 1994, Thorax.

[2]  E. Israel,et al.  Acetazolamide and furosemide attenuate asthma induced by hyperventilation of cold, dry air. , 1992, The American review of respiratory disease.

[3]  K. Chung,et al.  Protective effect of loop diuretics, piretanide and frusemide, against sodium metabisulphite-induced bronchoconstriction in asthma. , 1992, The European respiratory journal.

[4]  I. Pavord,et al.  Inhaled frusemide and exercise induced asthma: evidence of a role for inhibitory prostanoids. , 1992, Thorax.

[5]  I. Pavord,et al.  Effect of inhaled prostaglandin E2 on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma. , 1991, Thorax.

[6]  K. Chung,et al.  Effect of inhaled furosemide and bumetanide on adenosine 5'-monophosphate- and sodium metabisulfite-induced bronchoconstriction in asthmatic subjects. , 1991, The American review of respiratory disease.

[7]  K. Chung,et al.  Effect of inhaled furosemide on metabisulfite- and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects. , 1990, The American review of respiratory disease.

[8]  H. Endou,et al.  Furosemide directly stimulates prostaglandin E2 production in the thick ascending limb of Henle's loop. , 1989, The Journal of pharmacology and experimental therapeutics.

[9]  R. M. Refini,et al.  Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions. , 1989, The New England journal of medicine.

[10]  M. Robuschi,et al.  PREVENTION OF EXERCISE-INDUCED BRONCHOCONSTRICTION BY INHALED FRUSEMIDE , 1988, The Lancet.

[11]  P. Burney,et al.  Estimation and repeatability of the response to inhaled histamine in a community survey. , 1987, Thorax.

[12]  K. H. Leung.  Selective inhibition of leukotriene C4 synthesis in human neutrophils by ethacrynic acid. , 1986, Biochemical and biophysical research communications.

[13]  N. Chakravarty,et al.  Plasma membrane adenosine triphosphatases in rat peritoneal mast cells and macrophages--the relation of the mast cell enzyme to histamine release. , 1978, Biochemical pharmacology.